The majority of patients diagnosed with metastatic melanoma from 2017–2018 were tested for BRAF status and almost half of the patients with BRAF testing had a mutant BRAF test result (41.8%), which is consistent with estimates from large American studies [17,35]. Here, BRAF is linked to metastatic melanoma.